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INTRODUCTION 
Upper Gastrointestinal bleeding is a common potentially life threatening 
condition associated with high morbidity, mortality and  medical  care 
costs. Clinically manifests as haematemesis and, or melena and rarely 
haematochezia with or without haemodynamic compromise. 
Upper Gastrointestinal bleeding is  defined  as  bleeding  proximal  to the 
ligament of Treitz. The  incidence of UGI bleeding is  approximately 100  
cases  per  100,000 population  per  year. Mortality rates from UGI  
bleeding are  6 – 10 % overall[1]. Accurate  patient  evaluation and  
appropriate  early  management  is  critical  to  decrease  the  morbidity  
and  mortality. The  foundation  of  diagnosis  and  management  of  
patients  with  Upper  GI  Bleeding  is  Oesophago-Gastro-Duodenoscopy 
(OGD). Endoscopy has a sensitivity of 92% for identification of the site of 
(AUGIB), with a specificity that approaches 100% , especially if it is done 
within the first 24 hour of (AUGIB)[2] .  Various  scoring  systems  have  
been  used in  the  prediction  of  risk  in  patients  with  Upper  GI  
bleeding  and  early  stratification  in  accordance  with clinical  symptoms.  
Non  variceal bleeding  is  due to  arterial haemorrhage  such  as  ulcers  
and  deep  mucosal tears,  where  as  swollen  veins  due  to  portal  
hypertension  cause   variceal   bleeding   and  should  be  managed  
accordingly[3]. 
AIMS AND OBJECTIVES 
1. This  study  reviews  the  clinical  presentation , diagnostic  
modalities  and  evaluation  of  Upper GI  bleeding. 
2. To  analyse  the  incidence  and  severity  of  presentation. 
3. To  predict  the  prognosis  and  mortality  risk  of  Non variceal  
bleeding  using  Rockall  scoring  system. 
4. To  delineate  the  specific  cause  and  bleeding  site  using  OGD 
Scopy. 
5. To  analyse  various  modalities  in  the  early  resuscitation  and  
management  of  Upper  GI  bleeding. 
 
 
 
 
 
 
REVIEW OF LITERATURE 
HISTORICAL ASPECTS 
For more than 5000 years, upper Gastro Intestinal bleeding is one of the 
recognized causes of death. Various documents like Chinese manuscripts, 
Egyptian papyri, medical works of Hippocrates and not to forget famous 
Indian Surgeon,Sushruta, all have mentioned the upper gastrointestinal 
bleeding(non variceal) as one of the conditions associated with very high 
mortality. During ancient times, it was gradually brought to notice by 
symptomatology of the patients[4]. There were lot of evidences regarding 
the incidence of peptic ulcer were studied since from first century [5] 
.Morgagni in 1700 was the first person to describe the gastrointestinal 
bleeding because of portal hypertension[6]. Only at the turn of the 20th 
century with advent of endoscopy, evidence of haematemesis due to 
rupture of esophageal varices has been well established. Most of the earlier 
pioneers in esophageal endoscopic procedures including Crafoord used 
rigid endoscope (Negus Type). Now the flexible fibreoptic endoscope( 
Introduced in 1980 ) has replaced the rigid scope in almost all centres, 
which is supported by the result of controlled trial from Capetown. 
Endoscopy is now 50 years old and has established strongly it’s place in 
diagnosis and treatment of disorders of upper gastrointestinal tract both in 
emergency and non emergency situations. Crafoord and Frenckner from 
Sweden were first to use sclerotherapy in 1936 to treat esophagealvarices 
in a 19 year old patient. In 1990, Stiegmann published the ligating device 
using rubber or latex for varices. Spices and herbs were used in ancient 
times to treat Peptic ulcer disease. The changes in our management of 
gastrointestinal 
bleedingoverthecenturieshavebeendrivenbynaturalalterationsinthespectrum
ofdiseases,expanding our understanding of these diseases and the never 
ending advances in technology and pharmacology that have occurred 
relative to Upper Gastrointestinal diseases. 
ANATOMY 
OESOPHAGUS 
Oesophagus is a fibro muscular tube which extends from cricoid Cartilage 
(C6, vertebra) to Oesophago gastric junction (T11, Vertebra)measuring 
25cms. It is divided into cervical, thoracic and abdominal oesophagus. An 
anatomical sphincter is at the upper end of the oesophagus and 
physiological sphincter at the lower end of the oesophagus. In passing a 
Oesophago Gastro Duodenoscope, Cricopharyngeus sphincter can be 
identified which opens and closes intermittently.[7] 
BLOOD SUPPLY 
ARTERIAL SUPPLY 
Inferior thyroid arteries: 
The paired inferior thyroid arteries supplies the cervical esophagus that 
gives off branches called tracheoesophageal arteries 
Tracheobronchial and Bronchoesophageal arteries: 
The tracheobronchial arteries give off multiple small branches to the 
esophagus which subdivide within the periesophageal tissue. Commonly, 
one bronchoesophageal artery originates 1 cm to 3 cm caudal to the 
vascular bundle from the anterolateral aspect of the descending aorta. 
Aortic proper Oesophageal Artery: 
It arises from the anterior aspect of the descending aorta. 
Left Gastric and Splenic Arteries: 
The left gastric artery mainly supplies the anterior and right lateral aspects 
of the esophageal wall. The splenic artery primarily supports the posterior 
and left lateral aspects (cardiac notch) by either one or two direct branches 
or by vessels of the gastric fundus, including connections with the short 
gastrics 
  
 
 
Venous Drainage: 
The extrinsic veins drain into the locally corresponding large vessels. The 
superior vessels drain to the jugular veins or the azygos and hemiazygos 
veins. The inferior veins terminate in the left gastric and splenic veins. 
STOMACH: 
The stomach is divided into, Cardia, fundus, body and pylorus. 
BLOOD SUPPLY: 
ARTERIAL SUPPLY: 
Left Gastric Artery: 
In more than 90% of individuals, the left gastric artery  is a branch of the 
celiac axis. The left gastric artery commonly divides into an anterior and a 
posterior branch before attaining the lesser curvature, it bifurcates into an 
anterior branch which sends branches to the anterior gastric wall, and a 
posterior branch which, similarly, supplies the posterior gastric wall. The 
anterior branch of the left gastric artery angles rather obliquely across the 
body of the stomach toward the greater curvature. It ends in numerous 
small ramifications and forms a vascular "crow's foot" (of Payne)  and the 
posterior branch follows the lesser curvature a centimeter or two from its 
edge until it anastomoses with the right gastric artery The anterior and 
posterior gastric branches may possess direct interconnections with one 
another or with the continuing segment of the parent left gastric artery. 
 
Right Gastric Artery: 
The right gastric artery is a small branch which arises most 
commonly from the proper hepatic artery( 62% ) but also arises from left 
hepatic artery, rarely from common hepatic.A. It  gives origin to one or 
more suprapyloric branches. 
Gastroduodenal Artery: 
The gastroduodenal artery  arises as one of the two terminal branches of 
the common hepatic artery. It gives origin to the supraduodenal, 
retroduodenal, and posterior superior pancreaticoduodenal arteries. 
Right Gastorepiploic Artery: 
The right gastroepiploic artery  is a branch of the gastroduodenal 
artery (or its continuation) in most cases. After giving origin to an 
infrapyloric branch, the artery passes along the greater curvature of the 
distal gastric surgical unit within the gastrocolic ligament. The gastric 
branches of the right gastroepiploic artery pass mostly undivided in a 
submucosal position about one-fifth of the distance from the greater 
curvature. They anastomose extensively with branches from the left gastric 
artery. 
Left Gastroepiploic Artery: 
It arises in most cases (75%) from the distal splenic, inferior splenic 
terminal, middle part of the splenic trunk, or superior splenic terminal. It is 
the largest branch of the splenic artery gives off the left epiploic and the 
anterior epiploics. 
Short Gastric Arteries: 
Approximately five to seven short gastric arteries arise from the terminal 
branches of the splenic artery or from the left gastroepiploic artery. 
Venous Drainage: 
The venous supply of stomach  usually accompany the corresponding 
arteries. A great venous arch can develop between the left and right 
gastroepiploic veins during portal hypertension, forming a congested 
vascular bridge between the splenic and portal veins. 
DUODENUM: 
The duodenum has 4 parts: 
The first (superior) part, or bulb (5 cm), The second (descending) 
part or C loop (10 cm),The third (horizontal) part (7.5 cm), The fourth 
(ascending) part (2.5 cm) continues into  jejunum at duodenojejunal 
flexure. 
Blood supply: 
Arterial supply: 
 
 
 
 
 
 
 
 
 
 
 
 
 
The first part of the duodenum is supplied by the supraduodenal artery  and 
the postero superior pancreaticoduodenal branch of the gastroduodenal 
artery. The remaining three parts of the duodenum are supplied by an 
anterior and a posterior arcade. 
Venous Drainage: 
Veins of the lower first part of the duodenum and the pylorus usually open 
into the right gastroepiploic veins  they are the subpyloric veins while the  
upper first part of the duodenum is drained by suprapyloric veins. The 
venous arcades draining the remaining duodenum follow the arterial 
arcades and tend to lie superficial to them. 
PORTAL VEIN: 
The superior mesenteric and splenic veins join posterior to the neck of the 
pancreas to form the main portal vein[9]. It receives pyloric and coronary 
vein branches as it courses cephalad and obliquely to the right to form the 
most posterior structure within the hepatoduodenal ligament (portal triad). 
In the hilum of the liver, the main portal vein bifurcates into a short 
oblique right portal vein and a longer, more transverse, and more 
superficial left portal vein[10] . These branches then enter the parenchyma 
and become invested along with the other components of the portal triad 
by extensions of Glisson's capsule. 
Porto systemic collaterals: 
Multiple anastamoses forming between the portal and systemic circulation 
contributing the collateral circulation as follows, 
• Lt gastric vein anastamose with oesophageal veins. 
• Superior rectal vein with middle and inferior rectal veins. 
• Para umbilical veins with anterior abdominal wall subcutaneous 
veins. 
• Splenic and pancreatic vein tributaries anastomose with left renal 
vein retroperitoneal area[13]. 
• Veins over the bare area of liver anastomose with with the veins of 
the diaphragm and rt. internal thoracic vein[14]. 
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EPIDEMIOLOGY: 
The age distribution varies depending on the studied population  affecting 
the elderly in the west [16,17]. The male:female ratio for (AUGIB) in 
many European countries and the United States is approximately 2:1 
.There is regional variation regarding the frequency of causes of (AUGIB) 
depending on the demographic characteristics of the studied population, 
risk factors of bleeding, timing of the study and pathological 
classification[17].The incidence rates of UGIB demonstrates  a large 
geographic variation ranging from 50 to 160 cases per100 000 population, 
with consistent reports of higher incidences among men and elderly 
people. Possible explanations for this reported geographic variation in 
incidence are differences in definition of UGIB in various studies, 
population characteristics, prevalence of alcoholism, ulcerogenic 
medication, in particular aspirin, nonsteroidal anti-inflammatory drugs 
(NSAIDs), and Helicobacter pylori(H. pylori) prevalence[18,21]. Acute 
variceal bleeding has a significant mortality which ranges from 5% to 50% 
in patients with cirrhosis[23].  Some studies have reported a significant 
decline in incidence of acute UGIB, especially peptic ulcer bleeding, in 
recent years[22,23].This decline is likely due to a combination of factors, 
including decreasing prevalence of gastric colonization with H. pylori, the 
use of eradication therapy in patients with ulcer disease, and the increased 
use of PPI therapy,both in general and in patients using aspirin and 
NSAIDsin particular.  Despite the introduction of therapeutic endoscopy 
and acid-suppressive therapy, the overall mortality of UGIB has remained 
stable over recent decades and is still 6%-14% in most studies[24] . As 
such, mortality from UGIB is strongly associated with advanced age and 
presence of severe comorbidity. The risk of mortality increases with 
rebleeding, which is thus another major outcome parameter. It was noticed 
that, mortality due to haemetemesis after admision was more than those 
who admitted with symptoms[25] . The incidence of rebleeding in patients 
with UGIB shows a wide range from 5% - 20%, depending on several 
factors. One of the prognostic index of rebleeding was increased portal 
pressure > 15 mmHg,  and the same was also confirmed in a study of 
Moitinho et al[26]. 
More than  25 percent of episodes of UGI bleeding were due to pepti 
ulcers among 7800 individuals included in a database of USA between 
1999 and 2001[27]. Nonspecific mucosal abnormalities appeared to be 
commonest(40 percent), while Oesophagitis in 12 percent, and 
Oesophageal and gastric varicesin about 10 percent. Other causes (AV 
malformations, Mallory-Weiss tears, and GI tumors) were seen in  less 
than 5 percent of cases. Among the patients with peptic ulcer disease, 
gastric ulcers were seen in more than fifty percent than duodenal 
ulcers[28]. 
In another study focused on OGD performedfor a period of 4 years from 
the year 2000 in a setting,  the endoscopic findings that was common in 
patients with UGIB were Peptic  ulcer (31 percent) followed by an Gastric 
or duodenal erosion (20 percent). Gastric ulcers in OGD were dominant 
than duodenal ulcers (54 vs 36 percent)[29]. 
Recent epidemiological studies had revealed a decrease in incidence of all 
causes of UGIB  except those of peptic ulcer bleed. Bleeding due to 
varices seems be the leading cause of bleeding in cirrhotic patients in 50-
60%[30]. Rebleeding in occurs in 10-16%, despite the therapeutic 
modalities. Mortality ranges between 3 to 12 % and does not pose a change 
in the last few years. NSAIDs was only used in 12% of the individuals 
who were presented with bleeding. H. pylori infection is found in about 
45% of individuals with bleeding peptic ulcer. H. pylori should be kept in 
mind in all patients with peptic ulcer and eradication should be given. 
Child, in his classic monograph emphasized the co-existence of hepatic 
disease and manifestations of portal hypertension. It was only in the turn of 
twentieth Century that Gilbert and associates, and Pichancourt coined the 
term “portal hypertension”. At the same time several pathologists related 
ETIOLOGY
PEPTIC ULCER DISEASE 
GASTRODUODENAL 
EROSIONS
OESOPHAGITIS
VARICES
MALLORY WEISS TEAR
UGI MALIGNANCIES
the formation of esophago gastric varices to portal hypertension[30].The 
incidence of varices from 5%to15% ofpatients with cirrhosis per annum. 
ETIOLOGICAL FACTORS: 
According to various studies, the incidence of etiological factors were as 
shown below, 
PEPTIC ULCER 40% 
NO OBVIOUS CAUSE 15% 
EROSIVE DISEASE 15% 
OESOPHAGITIS 10% 
OTHERS 6% 
MALLORY WEISS TEAR 5% 
VARICES 5% 
NEOPLASM 4% 
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Peptic ulcer disease: 
Peptic ulcers are focal defects in the gastric or duodenal mucosa that 
extend into the submucosa or deeper to it. They may be acute or chronic  
caused by an imbalance between mucosal defenses and acid injury. 
Common sites for peptic ulcers are the 1st part of the duodenumand the 
lesser curve of the stomach, but they also occur on the stomal site 
following gastric surgery[32]. It remains as the most common cause of life 
threatening UGIB. Bleeding mainly occurs from the underlying arterial 
erosion and it depends upon the size of the erosion and diameter of the 
vessel.  There are 5 types of gastric ulcer, classified depending upon the 
anatomical location. Among these types, Type I seems to be the common 
ulcer located near the incisura angularis of lesser curvature. 
H.pylori is the most important factor in the development of peptic 
ulceration. About  3 /4 of duodenal ulcers and 1 /4 of gastric ulcers were 
caused by H.pylori infection. With the use of antibiotics, the prevalence of 
the infection have been much decreased in USA. The other factors 
associated with peptic ulcer formation are stress induced, NSAIDs intake, 
smoking and alcoholism. even after treatment with proton pump inhibitor 
therapy[33]. 
 
Mallory weiss tear: 
These are tears seen at the oesophago gastric junction, that cause UGIB. 
Due to continuous vomiting or with retching, haemetemesis occurs and are 
commonly associated with alcoholism and chemotherapeutic agents like 
cisplatin etc[35]. 
Portal Hypertension: 
The portal venous system contributes approximately 75% of the blood and 
75% of the oxygen supplied to the liver[31].  In the average adult 1000 to 
1500 mL/min of portal venous blood is supplied to the liver. However, this 
amount can be significantly increased in the cirrhotic patient. The portal 
venous system is without valves and drains blood from the spleen, 
pancreas, gallbladder, and abdominal portion of the alimentary tract into 
the liver[34]. Tributaries of the portal vein communicate with veins 
draining directly into the systemic circulation. These communications 
occur at the gastroesophageal junction, anal canal, falciform ligament, 
splenic venous bed and left renal vein, and retroperitoneum . The normal 
portal venous pressure is 5 to 10 mmHg, and at this pressure minimum  
blood is shunted from the portal venous system into the systemic 
circulation. As portal venous pressure increases, however, the 
communications with the systemic circulation dilate, and a large amount of 
blood may be shunted around the liver and into the systemic 
circulation[37]. 
A WHVP or direct portal venous pressure that is >5 mmHg greater than 
the inferior vena cava (IVC) pressure, a splenic pressure of >15 mmHg, or 
a portal venous pressure measured at surgery of >20 mmHg is abnormal 
and indicates portal hypertension. A portal pressure of >12 mmHg is 
necessary for varices to form and subsequently bleed[38]. 
Depending on this, the etiological factors implicated in portal 
hypertension can be categorized into four major groups: 
1.   Increased Hepatic portal flow. 
2.   Extra Hepatic outflow obstruction. 
3.   Obstruction of the extrahepatic venous systems. 
4.   Intrahepatic obstruction. 
90% of the cases with portal hypertension are due to intrahepatic 
obstruction. 
Causes for portal hypertension: 
I. Cardiac diseases 
1. Right ventricular failure 
2. Tricuspid stenosis 
II. Vascular diseases: 
1. Budd- chiari syndrome 
2. Membranous obstruction of the Inferior Vena Cava 
3. Thrombosis of the inferior vena cava. 
III. Acute and chronic Liver diseases 
1. Cirrhosis. 
2. Idiopathic portal Hypertension. 
3. Schistosomiasis. 
4. Congenital hepatic fibrosis. 
5. Exposure to environmental toxins. 
6. Metastatic carcinoma. 
IV. Venous Occlusion of Portal System. 
1. Portal Vein 
2. Splenic Vein 
Oesophageal Varices 
The shunting of esophageal collaterals or varices, are the most important 
clinically, because of their predilection to bleeding. The development of 
this portosystemic shunting depends upon a threshold portal pressure 
below which varices do not occur unless the portal pressure, as measured 
by the hepatic vein wedge pressure gradient is greater than 12mmHg, 
varices and variceal haemorrhage do not develop[39]. As all the four layers 
of veins in the wall of esophagus are intercommunicating, they all become 
engorged and elongated, dilated and tortuous when the pressure is above 
12 mm of Hg. However, the deep intrinsic veins seem to bear the brunt of 
the insult and dilate massively becoming esophageal varices, which are 
seen endoscopically. These vessels lie in the lamina propria, where they 
are poorly supported by surrounding tissue bulge into the lumen. 
Oesophageal varices are classified into, 
• Grade 1: varices that looks small and straight. 
• Grade 2:  varices  that are occupying less than 1 /3rd of the lumen 
• Grade 3: varices that are large, coil shaped occupying > 1 /3rd of  the 
lumen. 
• Grade 4 : Near complete occlusion  of oesophageal lumen. 
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Gastric Varices 
Short gastric veins presenting at the fundus communicate with the deep 
intrinsic venous plexus of the esophagus, which due to back pressure 
changes result in gastric varices of fundal type. They are common in 
extrahepatic obstruction like  splenic vein thrombosis. There is diffuse 
increase in arterio-venous communications between muscularis mucosa 
and dilated pre-capillaries. This is termed as congestive gastropathy[37]. 
They have a particular risk of bleeding and of damage eg. By Aspirin or 
NSAIDs. Therefore bleeding gastritis constitutes 30% of upper 
gastrointestinal tract bleeding in portal hypertension patients. 
Gastric varices are classified primarily by their location as, 
A. Gastroesophageal varices 
Type I (GEV 1)- along the lesson curve (2-5cm in length) 
Type II (GEV 2) – along the greater curve extending towards the gastric 
fundus 
B. Isolated Gastric Varices 
Type I (IGV 1) – Isolated cluster of varices in gastric fundus 
Type II (IGV 2) – Isolated gastric varices in other parts of the stomach 
Upper Gastrointestinal tract tumours: 
Oesophagogastric tumours are uncommon cause of acute upper 
gastrointestinal bleeding. The important benign type is gastrointestinal 
stromal cell tumour (GIST) arising  from the muscle layers of the gastric or 
duodenal wall. Erosion through the mucosa gives a characteristic 
umbilicated in endoscopy. These tumours may cause major bleeding by 
eroding the underlying arteries.  Acute GI bleeding due to malignant 
lesions are unusual (6%) arising from the oesophageal malignancies 
presents as  massive bleeding  due to aortic invasion. Significant 
gastrointestinal bleeding is uncommon with gastric cancer; however, 
hematemesis does occur in approximately 10% to 15% of patients[43]. 
Dieulafoy lesion: 
It is rare cause of Upper GI bleeding. It comprise about 3 – 6 % of all 
gastrointestinal bleeds in adults. They are thought to be of developmental 
malformation and are often called as, cirsoid aneurysm, and submucosal 
arterial malformation. They can occur anywhere in the GI tract, and most 
commonly in the proximal part of the stomach[40]. 
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 Arterio venous malformations: 
Arteriovenous malformations (AVMs) are abnormal blood vessels seen in 
the gastrointestinal (GI) tract and are the source of bleeding. They are 
identified nowadays by the use of angiography[41]. Presentation could be 
of massive UGI bleeding or anaemia of chronic blood loss. 
Other causes: 
Other rare causes of UGIB should also be considered in patients with 
UGIB. For example, In patients with chronic pancreatitis who presents 
with UGIB, Hemosuccus pancreaticus must be excluded. Bleeding in these 
patients can be secondary to a pseudoaneurysm in peripancreatic blood 
vessels as a complication of pancreatic pseudocysts[42]. Hemobilia is 
another rare cause of UGIB that should be considered in the setting of 
recent hepatobiliary tree instrumentation, such as with ERCP  ( Endoscopic 
retrograde cholangio pancreatography) or laparoscopic cholecystectomy 
possibly due to the injuries of bile duct and hepatic artery. Aortoenteric 
fistula must be considered in patients with a history of intra abdominal 
vascular surgery, such as Abdominal aortic aneurysm repair.  Post 
chemotheraphy or radiation sequelae may also be considered. Finally, 
Iatrogenic injuries secondary to endoscopic procedures, such as 
percutaneous endoscopic gastrostomy tube placement, are also rare causes 
of UGIB. portal gastropathy, Ménétrier's disease, and watermelon 
stomach(Gastric Antral Vascular Ectasia) should also be considered. 
Clinical features: 
All patients presenting  with Haemetemis or Malena with associated 
symptoms provides clue to the diagnosis as follows, 
1. Symptoms due to Oesophagitis or Peptic ulcer disease. 
2. Symptoms pertaining to Upper GI malignancies. 
3. Symptoms consistent with the cause of portal hypertension 
4. Symptoms of portal hypertension 
5. Symptoms directed towards the esophageal Varices. 
Clinical features vary depending upon the underlying causes like,  Peptic 
ulcer disease usually have relationship of symptoms pertaining to food 
intake, Gastric malignancies have  Ball rolling movements and symptoms 
suggestive of Gastric outlet obstruction[43] and cirrhosis patients have 
features of   Liver failure like Spidernaevi, Foetor hepaticus, 
Gynaecomastia, Testicular atrophy, Palmar erythema, peripheral edema , 
Flapping Tremors and Hepatic encephalopathy [31]. Clinical features of 
portal hypertension like Ascites, Splenomeagaly with Hyper splenism, 
caput medusae should be noted. Patient may come with severe 
Haematemesis and Melaena in the case of  ongoing or massive bleeding 
due to Erosive gastritis, Malignancies,  Esophageal or Gastric varices. 
Investigations: 
Complete Blood Count: 
Haemoglobin and hematocrit , Total Count, Differential count , E.S.R, 
Packed Cell volume (P.C.V), Platelet count. 
Bleeding time, Clotting time, Pro thrombine Time 
Renal Function Test: 
Blood Sugar, Blood Urea, Sr. Craetinine. 
Blood Grouping and Rh typing 
Urine routine 
Liver Function Test: 
 Serum Bilirubin 
 Serum proteins 
 Albumin: Globulin ratio 
 Serum Asparate amino transferase (AST, SGOT ) 
 Serum Alanine amino transferase (ALT, SGPT) 
 Serum Alkaline phosphatise 
Chest X ray PA view. 
X ray Abdomen AP erect view. 
ECG. 
Barium Swallow and Barium meal:  Linear filling defects in the distal 
esophagus and stomach can be made out depending upon the underlying 
pathology. 
Endoscopy( Oesophago Gastro Duodenoscopy) : Gold standard for the 
diagnosis of varices . This is the single most important investigation when 
the patient comes with upper G.I. bleeding and Malena. The bleeding site 
and the underlying cause can be identified by the use of OGD.  In 
Emergency situations it can be used diagnostic tool to identify the spurting 
artery, visible vessel / varices or stigmata of recent haemorrhage (SRH) 
and therapeutically to control bleeding[44]. 
Ultra sonography of Abdomen with Doppler evaluation 
 Ascites 
 Splenomegaly 
 Hepato megaly 
 Portal vein Caliber, splenic, hepatic vein and infra and intrahepatic 
IVC 
 Angiography 
 Measurement of portal pressure 
Liver biopsy:  To know the cause of intrahepatic portal hypertension. 
MANAGEMENT: 
Protocol for early management of acute upper gastrointestinal 
bleeding 
Triage 
Patients are prioritised depending upon the clinical presentation and 
decisions to be taken accordingly whether surgical intervention is needed 
or not. 
 
Intensive care monitoring 
Maintaining the circulation by accessing the central venous line, Nasal 
oxygen , urinary catheterisation to monitor the output, ryles tube insertion 
done to clear the blood filled stomach for endoscopy and also to asses the 
ongoing bleeding. Vital signs should be monitored periodically by using 
appropriate methods. 
General supportive therapy 
Endotracheal intubation should be attempted  if needed[45].  Patients can 
be resuscitated by using intravenous fluid administration, compatible blood 
transfusion, cardio pulmonary resuscitation, and management of associated 
comorbid diseases, such as sepsis, liver disease or  coronary artery 
disease[46]. OGD could be delayed until the patient is adequately 
resuscitated and stabilized with the available measures. Nasal oxygen must 
be given to counteract the blood loss which indirectly decreases the oxygen 
carrying capacity. Patients with acute UGIB  must be kept nil oral for the 
purpose of  the urgent need for OGD and for abdominal surgery if needed.  
They are  also assessed for hypovolemic shock  to determine requirements 
of intravenous fluid  administration and blood transfusion, and attention 
should be paid for comorbid diseases, especially coronary artery disease. 
Intravenous access is secured at two or more sites using 16 or 18 -gauge 
venflons. 
Patients with active UGI  bleeding should receive initial 500mL of  
crystalloids, during the first half an hour to maintain the blood pressure, 
while several units of packed redblood cells are cross matching and 
typed[46]. Fluid administration  is subsequently raised  if the blood 
pressure falls. Transfusion requirements are determined by many factors, 
including the age of the patient, presence  or absence of comorbid ilnesses, 
cardiovascular status, hematocrit, and the quantity of blood loss, along 
with the current hematocrit level. Packed redblood cells are transfused in 
individuals who have significant blood loss, ongoing  bleeding, and in 
those patients who manifest cardiac, renal, or cerebral ischemia. Patients 
who presents with  variceal haemorrhage are conservatively transfused to a 
hematocrit of only 26 to 28 to avoid exacerbating the bleeding by 
increasing the portal pressure[47]. Fresh frozen plasma transfusion or 
Platelets transfusion is individualized according to multiple factors like, 
severity of bleeding, bleeding rate, presence of other bleeding diathesis, 
qualitative platelet defects, induced by NSAIDs [48]. 
 
 
ROLE OF ENDOSCOPY: 
OGD stands as the prime diagnostic and therapeutic tool for UGIB[49] . It 
accurately identifies the bleeding site and determines the specific cause and 
in more than 90% of individuals with acute UGIB [50]. OGD is the 
principal modality in diagnosing the type of bleeding and therapeutically it 
reduces the surgical intervention. Befor OGD, it advisable to provide 
proton pump inhibitor therapy[51]. Urgent OGD for  UGIB is ideal, which 
significantly improves the clinical outcome  in certain conditions like 
variceal bleeding and severe ongoing bleeding[52].  Stigmata of recent 
haemorrhage could be identified by performing OGD as early as possible. 
From this, the site and number of lesions are identified. Multiple scoring 
systems like Rockall, forrest classification etc are used for prognostic 
purposes and triage of patients with UGIB[53]. Local adrenaline injection,  
electrocautery or argon plasma coagulation(APC), and mechanical 
therapies like endoclips or banding are the available therapies with 
endoscopy. Combined with the clinical presentation and OGD findings, 
risk stratification can be made[54]. 
PEPTIC ULCER DISEASE: 
These ulcers are seen as craters in endoscopy. For controlling the 
bleding, adrenaline injection is the agent of choice, which should be given 
at the site of bleeding or surrounding the ulcer. Sclerosants like ethanol, 
sodium tetradecyl sulphate can also be useful [55]. The use of 
electrocautery, argon plasma coagulation was also justified. 
Reflux esophagitis: 
The endoscopic findings are erythematous mucosa, edema with exudates, 
ulceration and bleeding with increased vascularity. Ulcers due to 
oesophagitis can be efficiently treated with adrenaline injection or by using 
ablation therapies[56]. 
Mallory- weiss tear: 
A linear and longitudinal tear that are seen over the osophago gastric 
junction. Sometimes an erosion or scab are also identified during 
endoscopy. The role of therapeutic endoscopy is under evaluation[57]. 
Cameron lesion: 
The ulcers or erosions, that are seen over the gastric part within the hiatus 
hernia are termed as Cameron lesions. They are asymptomatic and are 
incidentally diagnosed during endoscopy. These lesions are uncommon 
cause of acute bleeding[58] and the therapeutic modalities are injection 
with adrenaline or APC. 
Portal gastropathy: 
This condition looks like an intense red lesion in a mosaic 
background, commonly noted in the fundus. Portal hypertension is 
commonly associated with it. Due to the diffuse nature of the lesion, 
therapeutic modalities in endoscopy are not useful[59]. 
Oesophageal and Gastric varices: 
Endoscopic sclerotherapy: 
 
 
 
 
 
 
 
Obliteration of esophageal varices by injecting sclerosants directly into the 
channel (Intravariceal), beside the channel (Paravariceal) or combination 
of both is called sclerotherapy[60]. 
Indications: 
1)  Emergency sclerotherapy can be performed immediately at the time 
of the diagnostic endoscopy. 
2)  It can be delayed until after the variceal haemorrhage has been 
controlled by conservative measures. 
3)  In patients for whom no other treatment is available, including those 
in whom surgery carries high risk, those who have undergone 
surgery but continue to bleed. 
4)  In patients prior to definitive surgery so that the patients condition 
can be improved.  Hence reduces the mortality. 
Mechanism of action: 
Intra variceal sclerosant injection acts by causing thrombosis (damage the 
intima) thus stopping the bleeding and preventing rebleed from particular 
vein. In paravariceal injection sclerotherapy bleeding stops by two 
mechanisms: 
1) By external compression of the bleeding varices (Peri vascular fibrosis) 
2) By variceal contraction. 
Endoscopic variceal ligation: 
 
Indications: 
1.  In acute variceal bleeding, the band ligation has to be done 
immediately after the diagnosis, to control the bleeding. 
2.  In the long term eradication of the esophageal varices. 
3.  Prophylactic band ligation of the esophagal varices has also 
been reported 
4.  In high-risk patients the band ligation is indicated, till the 
patients recover from the risks and become fit for surgery. 
5.  Indicated in patients who are not fit for surgery (definitive 
surgery). 
6.  Indicated in the esophageal variceal eradication along with the 
low volume sclerotherapy (intravariceal)[61] 
Mechanism of action: 
Band ligation of esophageal varices acts by mechanical obstruction, 
leads to strangulation of variceal tissue. The strangulation of the varices 
ligated is followed by ischaemic necrosis of the mucosa and sub mucosa of 
the varix. At 3-7 days after treatment, sloughing of the ligated tissue, at the 
site with shallow ulcerations occurs (1-2 mm deep) and they are 6-10 mm 
in diameter. At 14-21 days minimal residual varices are present, the 
vascular structures in the submucosa will be replaced by matured scar 
tissue. After 50-60 days at variceal site mature scar tissue, without any 
stricture is seen. 
Benign and malignant Upper gastrointestinal tumors : 
These are all rare causes of UGIB. Benign conditions like GIST and 
leiomyomas are seen as extraneous compression in endoscopy. 
MALTomas are seen as polypoidal mass with cerebroid like mucosal folds. 
Malignancies, more commonly adenocarcinoma stomach are seen as an 
ulcerative growth, ulcero proliferative lesion, bleeding irregular mass or 
stricture. Linitis plastica, seen as a noncompliant stomach wall. 
Secondaries in the stomach are visualised as polypoidal erosions or mass. 
They tends to rebleed and are having worst prognosis[62]. 
Dieulafoy lesion: 
During endoscopy, these lesions are visible as an elevated lesion with 
erosions around it. In majority of cases, dielaufoy lesions are seen in the 
upper half of the stomach along the lesser curvature. It is about 3 – 6 mm 
in diameter. Adrenaline injection, argon plasma coagulation, ligation with 
bands or clips are useful to arrest bleeding[63]. 
Angiodysplasia: 
These lesions appear as dark red, thick network of vessels, 2 – 6 mm in 
diameter. Initially, adrenaline injection is used to control haemostasis 
followed by APC[64]. 
Gastric antral vascular ectasia: 
The lesions which are seen as multiple folds radiating from the pylorus 
upto the antral region with red streaks at the proximal ends. They also 
termed as watermelon stomach. Due to its superficial and diffuse nature of 
the lesion, thermal ablation are useful[65]. 
Aortoenteric fistula: 
It carries a very high mortlity as it necessitates the emergency endoscopy. 
Aortoenteric fistula commonly seen in the lower 3rd of the duodenum[66]. 
Sometimes, a prosthetic mesh can also be seen during endoscopy. OGD 
must be deferred after identifying such lesion, as therapeutic procedures 
may cause alarming haemorrhage on disturbing the lesion. 
Repeat esophagogastroduodenoscopy 
Repeat endoscopy is useful at times to identiy the missed out lesions. 
Rebleeding from the lesions occurs with in three days of the first 
endoscopy and the relook endoscopy is generally not advisable 
regularly[67]. 
RISK STRATIFICATION: 
Several scoring systems  have been developed  to help predict the outcome 
of patients and to improve patient management and promote cost-effective 
use of hospital resources . 
The Rockall scoring system is used for risk stratification with the use of 
clinical presentation, comorbid factors and endoscopy findings. It can be 
done befor and after endoscopy for accurate calculation. Mortality can be 
predicted with the use of it. 
A total Rockall score of  < 3  is predictive of low risk of adverse outcomes 
and is appropriate for early discharge and/or outpatient management while 
a score of  > 8  is predictive of high mortality[68]. With Rockall scoring 
system, individuals with high and low risk strata are calculated. 
ROCKALL RISK SCORING SYSTEM 
Rockall Risk scoring system 
Variable Scores 
Age   (Years)  
< 60 Years 
60 - 79 Years 
>  80 Years 
0 
1 
2 
Shock  
Pulse < 100/min, SBP>100 mmHg 
Pulse > 100/min, SBP>100 mmHg 
Pulse < 100/min, SBP<100 mmHg 
0 
1 
2 
Co-Morbid Conditions  
No Major Co-Morbidity 
Cardiac Failure,   Ischemic Heart Disease 
Renal Failure,  Liver Failure, Disseminated  Malignancies 
0 
2 
3 
Diagnosis  
Mallory Weiss tear,  No Lesion Identified 
All other Diagnosis 
Malignancy of Upper GI Tract 
0 
1 
2 
Major Stigmata of Recent Haemorrhage  
None / Dark Spot Only 
Blood in Upper GI Track, Adherent  clot, Visible or 
Spurting  Vessel 
0 
2 
Evaluation of the bleeding lesion was determined  in  Forrest 
classification by using OGD findings alone and does not include clinical 
parameters[69]. 
Blatchford risk scoring system was used in patients with UGIB to predict 
the clinical outcome , using only the clinical parameters without 
endoscopic evaluation of bleeding lesion. 
CONSERVATIVE  MANAGEMENT: 
Management of Non-variceal bleeding: 
Gastric acid inhibits platelet aggregation, impairs clot formation, and 
promotes fibrinolysis; therefore, inhibiting gastric acid and raising the intra 
gastric pH to 6 or more may promote clot formation and decrease the risk 
of rebleeding. 
High-dose PPI therapy is defined as an initial bolus (Pantoprazole 80 mg) 
followed by continuous infusion (Pantoprazole 8 mg/h) for up to 72 h. 
Omeprazole can also be used with best results. 
Since H.Pylori is the leading causative factor in Peptic ulcer disease, the 
following regimen should be considered[70]. 
 
Anti-H.Pylori regimen: 
PROTON PUMP INHIBITORS THERAPY bd + 
CLARITHROMYCIN 500mg bd + AMOXYCILLIN 1g bd 
10 – 14 
days 
PROTON PUMP INHIBITORS bd  + 
CLARITHROMYCIN 500mg bd + METRONIDAZOLE 
500 mg bd 
10 – 14 
days 
PROTON PUMP INHIBITORS bd + BISMUTH 
SUBSALICYLTE 525mg qid + METRONIDAZOLE 
250mg qid + TETRACYCLINE 500mg qid . 
10 – 14 
days 
 
Radiological approach 
Transcatheter coil embolisation is commonly used as a therapeutic 
approach in patients with unidentifiable and uncontrollable bleeding with 
the routine measures Bowel ischaemia is less as there is good collateral 
supply of the stomach and duodenum[71]. 
Safety and effectiveness of  the procedure was explained in recent 
studies, in patients with acute GI bleeding. 
 
 
 
BEFORE AND AFTER EMBOLISATION OF GASTRODUODENAL. A. 
 
 
 
 
 
Partial splenic artery embolization (PSE) has been performed to treat  
Oesophageal and Gastric varices including portal hypertensive 
gastropathy. 
Management of Variceal bleeding: 
Numerous agents have been studied for the prevention and treatment of 
variceal hemorrhage. In practice, the list consists of vasopressin and its 
analogues, somatostatin and octreotide, nonselective β- blockers and 
nitrovasodilators. 
I. Vasopressin and its analogues: 
Vasopressin causes splanchnic arteriolar vasoconstriction and decreases 
portal tributary inflow with a resultant decline in portal pressures Standard 
dose: Vasopressin 20 units bolus over 20 minutes and continuous IV 
infusion 0.2-0.4 unit/min with NTG 40 µg/min. The morbidity of 
vasopressin has led to the development of analogues with fewer side 
effects such as terlipressin. This drug does not increase plasminogen 
activator activity but has the same effects as vasopressin on the coronary 
vasculature. 
II. Somatostatin and its analogues 
It is a naturally occurring tetradecapeptide found in the GIT. Octreotide is 
a structural analogue of somatostatin. Somatostatin is administered as a 
250 µg /hour IV bolus followed by continuous infusion of 250µg/hour for 
2-4 days. 
Octreotide is given as 50µg IV bolus followed by infusion of 25-50 µg 
/hour. Because somatostatin and octreotide have to be administered 
parenterally, their role has primarily been restricted to the management of 
the acutely bleeding cirrhotic patient[72]. 
III. β- adrenergic Antagonists 
They cause splanchnic arteriolar vasoconstriction and decrease portal 
venous inflow. Propranolol is the prototype nonselective β-blocker. 
In the long term, propranolol maintains a portal hypotensive effect in most 
subjects, but tachyphylaxis occurs in 50% to 70% of patients.. β-blockade 
is associated with numerous side effects such as bronchoconstriction, heart 
failure and impotence in cirrhotics. Their administration does not impair 
the hemodynamic response to acute blood loss. 
IV. Nitrovasodilators: 
Nitric oxide is one of the most potent vasodilators and plays an important 
role in pathophysiology of portal hypertension. Patients treated with 
isosorbide mononitrate together with either propranolol or nadolol had a 
greater sustained portal hypotensive effect. 
Balloon Tamponade: 
They are highly effective in controlling esophageal variceal 
bleeding, but temporarily. There are three types of tubes available 
They are: 
a)  Linton-Nachlas tube: It has only gastric balloon and three 
lumen. 
b)  Sengstaken Blakemore tube: Both gastric and esophageal 
balloons are present and have three lumen. 
c)  Modified sengstaken Blakemore tube or Minnesota tube: 
It has four lumen, one excess to prevent aspiration pneumonia. After 
testing the balloons for leak, it should be passed under sedation or 
anaesthesia (Local or General) in operation theatre, through nostril. Once 
the tube in the stomach is confirmed by aspiration and easy distensibility 
of the gastric balloon, (300-400 ml of air is used for inflation). So that the 
pressure is maintained between 20-30 mm of Hg. Tube is secured to the 
forehead with slight traction. Inflate the esophageal balloon to a pressure 
of 40 mm Hg. 
Removal of the tube: 
24 hrs after inflating the esophageal balloon if there is no bleeding, deflate 
the bulbs and remove the tube. If bleeding is present, we can keep the tube 
for further 24 hrs. 
Results: 
Several studies have shown 60-70% effectiveness. However, the rebleed 
rate is as high as 40-60%. Hence, this is as effective as pharmacological 
control. 
Transjugular intrahepatic portosystemic shunts 
In this procedure, a communication is made inbetween the portal vein ( 
intrahepatic branch ) and hepatic vein. Haemostasis is achieved > 80% of 
cases. Model of End Stage Liver Disease is the good mortality predictor 
after the procedure. It is not useful in patients with multi organ failure. 
CCF, pulmonary hypertension and portal vein thrombosis are 
contraindications of TIPSS[73]. 
SURGICAL MANAGEMENT: 
Non varicel bleeding: 
Despite major advances in endoscopic treatment, the incidence of 
emergency surgery has not significantly changed. Today, most patients 
undergoing operation for bleeding peptic ulcer have simple oversewing of 
a bleeding ulcer, or simple patch of a perforated ulcer, Truncal vagotomy 
or distal gastrectomy. Surgical interventions, such as ligation of the 
bleeding vessel  or excision of the aneurysm, should be  considered if 
embolization fails or is contraindicated in case of Hemosuccus 
pancreaticus. 
Vagotomy: 
These surgical procedures are associated with ulcer recurrence as carried 
out in emergency situations. Vagotomy with drainage procedures carry 
minimum ulcer recurrence rate [74]. 
 
 Gastrectomy: 
Surgical resection appears to be the only curative treatment for 
gastric cancer  and most patients with clinically resectable loco regional 
disease should have gastric resection. The standard operation for gastric 
cancer is radical subtotal gastrectomy. Reconstruction is usually by 
Billroth II gastro jejunostomy, but if a small gastric remnant is left (<20%), 
a Roux-en-Y reconstruction is considered. The operative mortality is 
around 2 to 5%. 
Variceal bleeding: 
1.  Portosystemic shunting: They are aimed at lowering the 
portal pressure and diverting the portal flow from around the gastro-
esophageal area. 
A) Total shunts: 
1) End to side portacaval shunt 
2) Side-to-side portacaval shunt 
3) Mesocaval shunt 
4) Proximal splenorenal shunt 
B) Selective shunts: 
1) Distal splenorenal shunt 
2) Coronary caval shunt 
C) Partial shunts 
Small diameter H-graft (sarfeh shunt) 
This is the standard for both the emergency and elective treatment. 
End to side Porta caval shunt was introduced in 1940’s, itself, the operative 
mortality is much higher in emergency situation when used as a last resort 
was 50% mortality rate, in elective patients it may be as low as 19% in best 
hands[75]. There is no role for prophylaxis. 
 
2. Devascularization procedures: 
a.  Splenectomy 
b.  Esophageal transection 
c. Esophageal transection and devascularization (Suguira 
procedure)20 
Many shunt techniques evolved of these distal splenorenal shunt is 
said to be most advantageous. 
The devascularization procedures carry mortality rate of 33% as 
compared to endoscopic procedures which is 24%. 
Contra-indications for emergency surgery are, 
1.  Presence of acute alcoholic hepatitis. 
2.  Marked coagulopathy that is uncorrectable 
3.  Presence of major systemic complications related indirectly to liver 
disease such as acute renal failure, frank sepsis etc. 
Child class ‘c’ is not a contraindication, infact they are resistant to 
conservative treatment. 
Liver Transplantation: Theoretically, it is the ideal therapy for all 
patients with chronic liver disease complicated by portal hypertension and 
variceal haemorrhage. This re-establishes low resistance portal outflow 
through the liver. Considering the availability of the donor, cost of both the 
procedures and immunosuppressive medication it is indicated for the 
treatment of selected patients with end stage liver disease that is medically 
and surgically intractable. 
MATERIALS AND METHODS 
STUDY DESIGN  :      Prospective study. 
SAMPLE SIZE :      100 patients admitted with upper GI 
bleeding . 
PLACE OF STUDY :    Trauma ward, Department of General 
Surgery, Government Stanley Medical 
College Hospital, Chennai. 
PERIOD OF STUDY :   1 Year. 
INCLUSION CRITERIA: 
All patients with age groups 20 to 85 years admitted with Upper GI 
bleeding in Trauma ward. 
EXCLUSION CRITERIA: 
Children and patients with age groups below 20 years with Upper GI 
bleeding. 
 
 
METHODS: 
• A Proforma will be made that includes detailed history, physical 
examination , basic investigations and other relevant investigations 
required. 
• Clinical diagnosis will be made accordingly. 
• Risk stratification will be done using Rockall risk scoring system. 
• Triage, intensive monitoring and general supportive therapy done 
for the patients will be recorded. 
• Endoscopic findings and various modalities of treatment are 
compared and analysed. 
 
RESULTS 
Total number of cases 
Mean Age of presentation 
Male : Female ratio 
CHART - 1 
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CHART – 2 
Age distribution among males and females
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Clinical severity of Upper Gastrointestinal bleeding: 
TABLE - 1 
Mild ( < 500 ml ) 58 
Moderate ( 500 – 1500 ml ) 36 
Severe ( > 1500 ml ) 6 
 
Clinical presentation : 
TABLE.2 
Haemetemis 100% 
Malena 45% 
Abdomen pain 69% 
Haematochezia 12% 
Heart burns 32% 
Jaundice 04% 
Previous Upper GIT surgery 01% 
Loss of weight and appetite 05% 
Foreign body ingestion 02% 
 
CHART - 3 
Co-morbidities: 
TABLE.3 
Hypertension
Diabetes
Coronary Artery Disease
Chronic liver disease
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Role of  Risk factors 
Smoking , Alcoholism and NSAIDS drug intake appears to be the major 
risk factors in patients presenting with Upper GIT bleeding.
CHART - 4 
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CHART - 5 
 
 
 
 
 
 
 
 
 
Alcoholism tends to be the major risk factor causing mortality in Upper 
Gastrointestinal bleeding in our study.
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OGD findings in our study : 
TABLE – 4 
OGD  FINDINGS Frequency Percent 
GASTRITIS 25 25 
EROSIVE GASTRITIS 13 13 
OESOPHAGITIS 9 9 
DUODENITIS 8 8 
MALLORY WEISS TEAR 5 5 
NORMAL STUDY 4 4 
DUODENAL ULCER 4 4 
GASTRITIS &DUODENITIS 3 3 
DUODENAL ULCER WITH BLEED 2 2 
DUODENAL ULCER WITH CLOT 2 2 
EROSIVE GASTRITIS & LAX LES 2 2 
GASTRIC ULCER 2 2 
LESSER CURVATURE GROWTH 2 2 
OESOPHAGEALVARICES 2 2 
OESOPHAGITIS& GASTRITIS 2 2 
ANTRO PYLORIC GROWTH 1 1 
BLEEDING FROM AMPULLA 1 1 
DIEULAFOY LESION 1 1 
DUODENAL ULCER & LAX LES 1 1 
FOREIGN BODY - NEEDLE 1 1 
FUNDAL VARICES&DUODENITIS 1 1 
GASTRIC POLYP 1 1 
GASTRIC ULCER WITH CLOT 1 1 
GASTRIC ULCER WITH SLOUGH 1 1 
GASTRIC VARICES 1 1 
LOWER OESOPHAGEALVARICES 1 1 
OESOPHAGEAL EROSION 1 1 
OESOPHAGITIS&GERD 1 1 
OESOPHAGITIS& LAX LES 1 1 
STOMAL ULCER 1 1 
Total 100 100 
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TABLE – 5 
ROCKALL SCORE
0 
1 
2 
3 
4 
5 
6 
Total 
 
 Frequency Percent
2 2.0 
22 22.0 
32 32.0 
27 27.0 
8 8.0 
5 5.0 
4 4.0 
100 100.0 
ROCKALL SCORE
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Impact of Rockalls score with mortality: 
Independent samples t-Test to compare mean rockall score between 
Survival and Death 
TABLE – 6 
 DEATH N Mean Std. Dev t-Value P-Value 
ROCKALL 
SCORE 
Survival 96 2.35 1.187 
5.215 <0.001 
Death 4 5.50 1.000 
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Conservative management : 
Initial Fluid Resuscitation ( crystalloids & colloids )  - 87% 
Blood transfusion                                                              -  82% 
Proton pump inhibitor therapy                                        -   88% 
CHART.8 
 
Initial fluid resuscitation with crystalloids and colloids were given in 87% 
of patients, 82% of patients were given blood transfusion and 88% of 
patients were managed with proton pump inhibitor therapy. 
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Intervention procedures:
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*  Therapeutic endoscopy
removal and variceal band ligation.
*  Radiological intervention
*  Laparotomy : 
• Under running suture over the bleeding vessel with Truncal 
vagotomy and pyloroplasty.
• Subtotal Gastrectom
resection. 
• Palliative Gastrojejunostomy.
• Feeding Jejunostomy.
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TABLE - 7 
Independent samples t-Test to compare mean age between 
Survival and Death in Upper GI bleeding. 
 DEATH N Mean Std. Dev t-Value P-Value 
AGE 
No 96 44.72 12.677 
0.769 0.497 
Yes 4 55.00 26.608 
 
CHART – 10 :   MORTALITY IN UPPER GI BLEEDING 
 
 
44.7 55.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
Survival Death
M
ea
n
 
v
al
u
e
Mean Age (years)
DISCUSSION 
Upper Gastrointestinal bleeding is one of the most common emergencies in 
the surgical department that carries 6 to 10 % mortality worldwide[1]. Our 
study was a prospective clinical study on evaluation and management of 
Upper gastrointestinal bleding in patients admitted in our institute 
(Government Stanley Medical College Hospital ) in one year. We excluded 
children and patients under the age of 20 years from this study. We 
assessed the clinical presentation, co-morbidities, associated risk factors, 
OGD findings ( within 24 hours of presentation ), need of initial 
resuscitation, blood transfusion and intervention procedures like 
therapeutic endoscopy, radiological intervention or emergency laparotomy. 
A total of 100 cases were take up for the study. In these patients, the mean 
age of presentation was 45 years with a standard deviation of 13. Minimum 
and maximum age of presentation in the final study was 20 and 79 years 
respectively with  sex distribution predominantly seen among males ( 89% 
) than females  ( 11% ). The maximum number of age group is between 31 
– 40 years as shown in the chart.2. 
The severity of bleeding was classified into mild, moderate and severe 
depending upon the quantity of blood loss. Majority of patients 
 ( 58% ) were presented with mild haemetemesis ( < 500 ml ), 36% 0f 
patients presented with moderate haemetemesis ( 500 – 1500 ml ) and only 
6% presented with severe haemetemesis ( > 1500 ml ) as shown in Table.1. 
We had 58 patients in mild, 36 patients in moderate and 6 patients in 
severe form of which 4 patients were died inspite of resuscitative 
measures. 
All of our patients admitted with haemetemis had Abdomen pain in 
69 of them. About 45 patients had malena, 12 patients were presented with 
haematochezia and 32 patients had history of heart burns. History of 
anorexia and weight loss were observed in 5 patients while jaundice were 
noted in 4 patients as shown in Table.2 and Chart.3. 
The mortality rate was 4% in our study  with mean age of survival and 
mortality being 44 and 55 year respectively. Thus elderly people withstand 
less well to UGIB than younger patients. The major contributing factor that 
leads to death was blood loss, which inturn leading to hypovolemic shock. 
The incidence of risk factors like Smoking, Alcoholism and NSAIDs drug 
intake were considered in our study and the impact with mortality have 
also been been compared. Smoking is seen in 57 % of patients while the 
incidence of alcohol was seen with 72 %.  Around 21 % of patients were 
having NSAIDs intake. This was surprisingly a small number compared to 
other studies like Theocharis GJ, Thomopoulos KC et al [21].Most of the 
patients took NSAIDS for arthritis and myalgia. Thus, it can be clearly 
delineated from the Chart.4 that alcoholism is one of the major risk factors 
causing Upper GI bleeding and almost, always associated with Peptic ulcer 
disease. Mortality rate also stands high in patients with alcoholism ( 75% ) 
than the other two risk factors ( 50% ) as shown in Chart.5. 
The associated co-morbid illness in our study were Hypertension 
(12% ), Diabetes ( 11% ), Coronary Artery Disease ( 19% ) and Chronic 
liver disease ( 5% ) as noted in Table.3. One of our patients died had 
associated history of old coronary artery disease and another patient had 
chronic liver disease leading to portal hypertension. Thus, it can be stated 
that, associated co-morbid factors had a strong link with mortality. 
OGD is very useful  to delineate the site of bleeding and to facilitate 
targeted therapy. It defines  the low risk and high risk  strata and helps to 
identify the appropriate candidates for a period of hospital stay or 
intervention procedures if neded. Risk – stratification scores that 
incorporate endoscopic data, such as the complete Rockall score, propose 
that such scores are superior to clinically based scores because they define 
a greater proportion of all patients at low risk for adverse outcomes related 
to acute upper gastrointestinal bleeding. The pattern of Upper GI bleeding 
in our study was shown in Table.4. The commonest OGD finding in our 
study was Gastritis ( 25% ), followed by Erosive gastritis ( 13% ). Thus, 
around 38% of the patients had gastric inflammation or erosions, of which 
32 patients were alcoholics. The second commonest cause was found to be 
Oesophagitis ( 9% ),  followed by  Duodenitis ( 8% ) and Mallory weiss 
tear      ( 5% ). There was not able to identify any lesion in about 4% of the 
individuals. More than a single site lesion like Gastritis + Duodenitis, 
Oesophagitis + Gastritis can be seen in 3 and 2 % of patients respectively 
while Gastric and Duodenal ulcers  were seen in 2 and 4% respectively. 
Stigmata of recent haemorrhage ( SRH ) were found in 5 patients with 
UGIB. Malignancies were noted in 4 patients of UGIB. In our study, 
stomal ulcer bleeding was seen only in 1 patient. A foreign body, needle 
was the cause of haemetemesis in one patient.  Variceal bleeding from 
Oesophageal and fundal varices constitute 4% of UGIB in our study. 
According to the study by Boonpongmanee et al[27], the most common 
endoscopic findings were Gastric ulcer  (23.1) and oesophageal varices 
(23.1), followed by Duodenal ulcer (13.9), Mallory weiss tear (10.2), 
Gastritis (4.7), Duodenitis (3.7) and Oesophagitis (3.7). According to the 
study by Silverstein et al[76],  24% had Duodenal ulcer,  24.4% had 
Gastritis/ Erosions, 22.3 % Gastric ulcer, 11.3 % Oesophageal varices,  
8.2%Mallory weiss tear, 7.3% Oesophagitis,  6.8% Duodenitis,  2.8% 
Neoplasms,  1.9% Stomal ulcer. 
Based on the clinical variables like age, the presence of shock and 
the presence of co-morbid illness, the clinical Rockall score was calculated 
for each patient with non variceal bleeding.  The original rockall scoring 
was calculated by totaling the clinical and endoscopic scoring systems. The 
scoring results of our set of patients were shown in the Chart.6 and 
Table.5. It clearly showed that  majority of the patients (32) were with the 
score of 2. Only 5 and 4 patients had the score of 5 and 6 respectively with 
mortality rate being 4% among them. Thus, it concludes that, higher the 
rockall score, higher the mortality with significant P value of  < 0.001 as 
shown in the Table.6.  The mean Rockall score was 2.4 and 5.5 among the 
survival and death respectively as shown in the Chart.7. Thus in our study 
we could stratify patients with a total rockall  score of 4 and below as low 
risk strata and with a score of 5 and above as high risk strata. Rockall 
scoring has been validated in multiple patient populations across a range of 
health sittings. It appears to be a valid predictive index that relies on 
clinical and endoscopic data for assessing the risk of subsequent recurrent 
bleeding and mortality in patients with acute UGIH. 
Patients presented with Upper GI bleeding in emergency ward was 
prioritized  to start initial resuscitation according to the clinical 
presentation. Peripheral line or Central venous line, Ryles tube insertion  
and Foley’s catheterisation would be started with intense monitoring of  
vital signs and urine output. Endotracheal intubation should be attempted 
in necessary conditions. 
Initial fluid resuscitation should be given with crystalloids like Ringer 
lactate or Normal saline of about 500 ml within the first 30 minutes, 
followed by colloids like haemacel to maintain the intravascular volume. 
Compatible cross matched blood transfusion should be started as soon as 
possible to counteract the blood loss due to haemetemesis. Fresh frozen 
plasma or Platelets  transfusion can also be given depending upon multiple 
factors, including bleeding severity, bleeding rate, presence of other 
coagulopathies, and presence of qualitative platelet defects, such as those 
induced by NSAIDs.  Cardio respiratory support, and treatment of 
significant comorbid diseases, such as sepsis or coronary artery disease 
must be given importance to prevent morbidity. Patients usually  receive 
supplemental oxygen by face mask or nasal prongs  to counteract the loss 
of oxygen carrying capacity from blood loss. In patients suggestive of Non 
variceal bleeding,  high-dose Proton pump inhibitor  therapy  i.e,  initial 
intravenous bolus of Pantoprazole 80 mg followed by continuous infusion 
(Pantoprazole 8 mg/hr) for up to 72 h should be given. This therapy ideally 
be given prior endoscopy. In our study, 87% of patients were managed 
with initial fluid resuscitation with crystalloids and colloids, blood 
transfusion was given in 82% of individuals and 88% of patients had given 
proton pump inhibitor therapy as shown in Chart.8. These results are hence 
comparable with Duggan.J.M et al[46] and Blair.S.D, Janvrin.S.B et al 
study[47]. 
Early OGD will significantly improves  the clinical outcome  in special 
circumstances requiring urgent endoscopic hemostasis, such as severe, 
ongoing hemorrhage or esophageal variceal hemorrhage. Bleeding form 
vaices is mainly because of dysfunction of liver and bleeding varices 
which are refractive to the treatment. The selection of therapy for bleeding 
esophageal varices remains controversial. Of all the modes of treatment, in 
recent years attention was focused on the relative merits of portosystemic 
shunting, devascularization of esophagus on one hand and the endoscopic 
procedures to control the bleeding from esophageal varices on the other 
hand. 
The use of endoscopy therapeutically, minimizes the blood transfusion 
requirements and reduces the length of stay in intensive care set up. 
Injection therapy can be done over the bleeding site using normal saline or 
diluted epinephrine. The use of Cautery devices like  heater probes, 
neodymium yttrium aluminum garnet lasers, argon plasma coagulation, 
and electrocautery probes were used to coagulate blood vessels( coaptation 
). Clips and band ligation devices were also deployed over the bleeding site 
to control it. In our study. therapeutic interventions were needed in 2 
patients whose OGD findings showed Gastric polyp and Foreign body. 
Endoscopic polypectomy and Endoscopic foreign body 
 ( needle ) extraction were done in the above said cases. 
Endoscopic variceal band ligation(EVL) was done in a patient who had 
presented with Upper GI bleeding and OGD showing Grade III 
oesophageal varices. The results from 6 randomised control trials showed 
that, Endoscopic variceal ligation is superior to Endoscopic sclerotherapy( 
EST )as evidenced from the study conducted by Luketic V.A et al[39] and 
a meta analysis has confirmed the superiority of EVL over EST by the 
study of Laine.L Cook.D et al[61]. It was stated that, Endoscopic variceal 
ligation should be repeated every 2 to 4 weeks to eradicate the varices. 
Concomitant Beta-blocker therapy should also be considered for effective 
treatment. 
Radiological intervention were required for  2 cases in our study. 
Angiography along with transcatheter embolisation  proved to be valuable 
as a non operative option for selected patients with non variceal upper 
gastrointestinal bleding as quoted in a study conducted by Rafique.M.Z et 
al[71]. Micro coils like, fibred platinum coils of size ranging from 2 – 10 
mm in diameter are used. These coils decreases the perfusion pressure thus 
allowing the  bleeding vessel to get thrombose, once deployed in a distal 
artery. Coil embolisation of Gastro duodenal artery was done and the 
patient was improved symptomatically. 
In our study, Laparotomy was done for 4 cases as shown in the Chart.9. 
The operations for bleeding duodenal ulcer are oversewing of the ulcer 
with or without vagotomy and drainage procedures. Oversewing alone is 
associated with higher ulcer recurrence but have lower mortality rate. 
Emergency laparotomy was done for a case of Refractory haemetemis with 
pharmacological and endoscopic management. OGD finding was duodenal 
bulb ulcer with visible spurting vessel. Endoscopic banding was failed due 
to continuous bleeding.  Laparotomy was done, under running sutures 
made over the spurting vessel followed by truncal vagotomy and 
pyloroplasty and can be compared with the study conducted by de la 
Fluente.S.G et al[74]. 
For other three patients with carcinoma stomach, fluid resuscitation and 
blood transfusion were given initially to stabilize the patient and thorough 
evaluation was made with investigations. Surgical resection of the growth 
with adequate margins is the only curative treatment for carcinoma 
stomach. R0 resection is the goal of surgical treatment. The standard 
surgery for stomach growth is, Radical sub total gastrectomy, Billroth II 
gastrojejunostomy with Roux en Y anastomosis. The operative mortality 
for this procedure is around 2 to 4 %[77]. Depending upon the per 
operative findings, procedure can be modified. Palliative procedures  like 
anterior gastrojejunostomy or Feeding jejunostomy can be undertaken in 
case of locally advanced or metastased gastric carcinoma. In our study ,  
Elective laparotomy was made and one patient with antro pyloric growth 
underwent subtotal gastrectomy, roux-en-Y anastomosis with D2 resection. 
Another patient with carcinoma stomach with transverse mesocolon 
infiltration was managed with palliative anterior gastro jejunostomy, while 
the elderly patient with advanced carcinoma stomach with peritoneal and 
liver secondaries underwent feeding jejunostomy. 
From the Table.7 and Chart.10, it can be stated that, the mean age of 
survival among the individuals with upper gastrointestinal bleeding was 44 
years and the mortality was seen among the patients with group of around 
55 years. 
 
 
 
 
SUMMARY 
• This prospective study of Clinical study, Evaluation and 
Management of Upper gastrointestinal bleeding was done in our 
institute ( Government Stanley Medical College Hospital ) on 100 
cases, who presented  with haemetemesis. The study period was 1 
year. 
• Upper Gastrointestinal bleeding is potentially a life threatening 
condition, commonly seen among males than females in the ratio of 
89 : 11 in our study. 
• The mean age of presentation is 45 years. 
• Most of the patients ( 58% ) presented to the emergency ward were 
with mild haemetemesis ( < 500ml ). 
• The most common clinical presentation is with haemetemesis 
accompanied with abdomen pain ( 69% ) and malena ( 45% ). 
• Association with co-morbid factors, increases the mortality rate. 
• Among the risk factors,  alcoholism tends to the major one ( 72% ) 
associated with  mortality ( 75% ). 
• Gastritis and Erosive gastritis appears to be the commonest OGD 
finding in our study. 
• It was concluded that, Rockall score plays a vital role in predicting 
the mortality. Higher the rockall score, higher will be the mortaliy. 
• Initial fluid resuscitation(87%), Blood transfusion(82%) and Proton 
pump inhibitor therapy(88%) were given to the individuals 
depending upon the clinical assessment. 
• Intervention procedures were done among 9 individuals in our study. 
Therapeutic endoscopy in 3 patients, coil embolisation in 2 patients, 
emergency laparotomy in 1 and elective laparotomy in 3 patients. 
• The mean age of mortality is being 55 years in our study. 
• Mortality rate in our institute was 4 in 100 cases in our study. 
 
 
 
 
 
 CONCLUSION 
• Upper gastrointestinal bleeding is one of the commonest 
emergencies all over the world. It has an incidence of about 50 to 
150 per 100,000 population every year. 
• The mean age of presentation of UGIB was 45 years with 
predominantly seen among males. 
• More than half of the patients presented to the emergency ward 
with mild haemetemesis where as mortality was found to be in 
individuals with severe haemetemesis. 
• Among the risk factors studied, alcoholism appears to be a major 
risk factor almost always associated with peptic ulcer disease and   
3/4 increased risk for mortality. 
• The associated co-morbid illnesses plays a significant role in 
deciding the mortality. 
• Oesophago-Gastro-Duodenoscopy was used as a diagnostic and 
therapeutic tool in the management of UGIB. The most common 
finding was Gastritis, followed by Erosive Gastritis. Thus, Peptic 
ulcer disease is the commonest cause of UGIB. 
• The Rockall score was used to triage the non variceal upper 
gastrointestinal bleed patients into low and high risk strata and it 
was proved that higher the Rockall score, higher will be the 
mortality. 
• Radiological and surgical interventions should be considered in 
patients refractory to conservative management, depending upon 
the circumstances. 
• Mortality rate in our institute is 4%, which is best explained by the 
availability of an Upper GI bleed centre and strict adherence to 
formed protocols. 
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                                PROFORMA 
CLINICAL STUDY, EVALUATION AND MANAGEMENT OF 
UPPER GASTRO INTESTINAL BLEEDING 
 
 
Patient details:            Patient ID No:……………………. 
 
Name  : 
Age/Sex  : 
IP No  : 
DOA  : 
DOP  : 
DOD  : 
Address   : 
 
Mobile No : 
 
History 
 
Occupation   :    Rural/Urban 
Socio Economic Status : Upper/UpperMiddle/LowerMiddle/Poor 
 Haemetemesis  : 
- Onset 
- Duration 
- Quantity 
- Episodes / Frequency 
- Association with Guiddiness / Fainting 
- Association with Malena 
 
Abdominal Pain 
- Onset 
- Duration 
- Nature 
- Severity 
- Radiation of pain 
- H/o Drug intake 
Past History 
 
- H/o Previous  episodes 
- H/o Previous  Surgeries 
- H/o DM /HTN/ PT/BA / IHD/ Liver Failure / Malignancies 
 
Personal History 
 
- Alcoholism , If any - Last Bout 
- Smoking 
- Tobacco / Betel Nut Chewing 
 
General   Examination 
 
- Consciousness and orientation 
- Pallor 
- Jaundice 
- Clubbing 
- Vital Signs : 
 
 
Pulse Rate    : 
Blood Pressure    : 
Spo2    : 
-   Ryles Tube Aspirate   : 
 
Examination of Abdomen 
 
 
 
 
 
 
Per Rectal Examination 
 
CVS  : 
RS  : 
CNS  : 
  
Investigations: 
 
• Complete blood count 
• Renal function tests 
• Liver function tests 
• Chest X ray PA View 
• X ray Abdomen AP erect view 
• ECG 
 
Early Resuscitation 
- Nasal 02 
- Intravenous Crystalloids / Colloids 
- Blood Transfusion according to blood Loss 
- Empiric Pharmacotherapy 
 
OGD Scopy Findings 
 
Non Variceal 
 
- Oesophagitis 
- Mallory - Weiss tear 
- Gastric Erosions / Gastritis 
- Gastric Ulcer 
- Duodenitis 
- Duodenal Ulcer 
- Neoplasm 
- Angiodysplasia 
- Dieulafoy lesion 
- Miscellaneous 
 
 
Variceal 
 
- Oesophageal Varices 
- Oesophago Gastric Varices 
- Gastric varices. 
 
Rockall Risk scoring system 
Variable Scores 
Age   (Years)  
< 60 Years 
60 - 79 Years 
>  80 Years 
0 
1 
2 
Shock  
Pulse < 100/min, SBP>100 mmHg 
Pulse > 100/min, SBP>100 mmHg 
Pulse < 100/min, SBP<100 mmHg 
0 
1 
2 
Co-Morbid Conditions  
No Major Co-Morbidity 
Cardiac Failure,   Ischemic Heart Disease 
Renal Failure,  Liver Failure, Disseminated  Malignancies 
0 
2 
3 
Diagnosis  
Mallory Weiss tear,  No Lesion Identified 
All other Diagnosis 
Malignancy of Upper GI Tract 
0 
1 
2 
Major Stigmata of Recent Haemorrhage  
None / Dark Spot Only 
Blood in Upper GI Track, Adherent  clot, Visible or 
Spurting  Vessel 
0 
2 
 
Management: 
Non -Variceal Causes 
 
- Endoscopic Band Ligation 
- Proton Pump Inhibitors 
- Anti H-pylori regimen 
Variceal Causes :- 
 
Managed in Cooperation with Medical and Surgical Gastro Enterology 
Department by, 
- Endoscopic Sclerotherapy 
- Endoscopic Variceal Ligation 
- Endoscopic Glue Injection 
Follow up 
 
- 24hrs 
- 1 week 
- 1 Month 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
-   
MASTER CHART 
                      
NAME IP.NO AGE SEX ALCOHOLISM SMOKING NSAIDS OGD  FINDINGS 
 
ROCKALL  
SCORE RESUSCITATION BLOOD
MARIYAPPAN 13612 35 M NO YES NO GASTRIC POLYP 1 NO NO
YASODHA 13716 40 F NO NO YES NORMAL STUDY 0 NO NO
MURUGAN 25132 30 M YES YES NO EROSIVE GASTRITIS 2 YES YES
RATHINAVEL 25612 42 M YES NO NO MALLORY WEISS TEAR 3 YES YES
MOHAMMAD ALI 13176 60 M YES YES NO OESOPHAGITIS 5 YES NO
RAMASAMY 27765 70 M YES YES NO DUODENAL ULCER 2 YES YES
VENKATESAN 24129 60 M NO YES NO OESOPHAGEAL VARICES 6 YES YES
MANI 26172 38 M YES NO NO MALLORY WEISS TEAR 1 YES NO
ANVAR BASHA 28861 62 M YES NO NO OESOPHAGITIS 2 YES NO
MUNUSAMY 29618 52 M YES YES NO GASTRITIS 5 YES YES
DHARMANDRAN 25001 35 M YES YES NO DUODENAL ULCER WITH CLOT 4 YES YES
PATCHAIPPAN 24126 58 M YES NO NO OESOPHAGEAL EROSION 3 YES NO
LOGANATHAN 27111 60 M YES YES NO DUODENAL ULCER 4 YES YES
ALAMELU 27574 42 M YES YES NO GASTRITIS 1 YES YES
MANICKAM 28112 62 M YES YES NO OESOPHAGITIS & GASTRITIS 1 YES YES
NADEEM BASHA 28612 78 M YES YES NO LESSER CURVATURE GROWTH 6 YES YES
RAMAMOORTHY 30061 56 M YES YES NO EROSIVE GASTRITIS 3 YES YES
NAINA 30965 18 M NO YES YES DUODENAL ULCER WITH BLEED 4 YES YES
DEEPAK JALOB 31216 49 M YES YES NO GASTRITIS &  DUODENITIS 3 YES YES
MANNAR 31132 44 M YES NO NO EROSIVE GASTRITIS 1 YES YES
KADHAR BASHA 31218 52 M YES NO NO DUODENITIS 3 YES YES
GANGADHARAN 31269 38 M YES YES NO OESOPHAGITIS & GASTRITIS 1 YES YES
ARUNACHALAM 31137 40 M NO YES YES GASTRITIS 2 YES YES
MANICKAM 26172 64 M YES YES NO EROSIVE GASTRITIS 5 YES YES
MUTHUMANI 29016 48 F NO NO YES GASTRITIS 2 YES YES
BASKARAN 31109 34 M NO YES NO NORMAL STUDY 1 YES YES
ILANGOVAN 31122 44 M YES YES NO EROSIVE GASTRITIS 1 YES YES
MOHAN RAJ 31061 38 M YES NO NO GASTRITIS 1 YES YES
CHELAPPAN 31078 58 M YES YES NO ANTRO PYLORIC GROWTH 3 YES YES
JAYA RAMAN 32161 53 M YES YES NO DUODENAL ULCER WITH CLOT 3 YES YES
THANGAVEL 31763 24 M YES NO NO GASTRITIS 2 YES YES
NATESAN 30176 64 M YES NO NO OESOPHAGEAL VARICES 4 YES YES
CHAKKARAPANI 31619 37 M NO NO YES OESOPHAGITIS & LAX LES 3 YES YES
MANJULA 31619 35 F NO NO NO OESOPHAGITIS 1 YES NO
SARGUNAM 30179 45 M YES YES NO GASTRIC ULCER 2 YES YES
RAJENDRAN 30888 59 M YES NO NO GASTRITIS &  DUODENITIS 3 YES YES
VASANTHA KUMAR 31767 28 M YES NO NO GASTRITIS 2 YES YES
CHANDRAN 31212 25 M YES NO NO DUODENITIS 1 YES YES
NAGARAJAN 32617 34 M YES YES NO EROSIVE GASTRITIS 2 YES YES
RAMESH 31769 36 M NO YES YES OESOPHAGITIS  1 YES NO
MUTHU 32361 78 M YES YES NO DUODENAL ULCER & LAX LES 3 YES YES
PALAYAM 33744 64 M YES YES NO GASTRITIS 2 YES YES
GURUMOORTHY 30921 42 M YES NO YES GASTRIC ULCER WITH CLOT 4 YES YES
RAMADOSS 30612 54 M YES NO NO EROSIVE GASTRITIS 3 YES YES
GANGADHARAN 30717 36 M NO NO YES STOMAL ULCER 4 YES YES
REICHEL 30597 45 F NO NO YES GASTRITIS 2 YES YES
PALANI 39181 40 M NO YES NO LESSER CURVATURE GROWTH 3 NO YES
ARUN PRAKASH 37165 24 M YES NO NO GASTRITIS 2 YES NO
NARASIMMALU 36543 49 M YES YES NO GASTRITIS 3 YES YES
RAJA 37754 33 M NO YES YES GASTRITIS 2 YES YES
MANOHARAN 35784 54 M YES NO YES GASTRIC ULCER 3 YES YES
RAMARAJU 38675 40 M YES YES NO DUODENAL ULCER WITH BLEED 5 YES YES
ANGAMUTHU 39687 50 M YES YES NO OESOPHAGITIS & GERD 3 YES NO
SARAVANAN 40124 23 M NO NO NO FOREIGN BODY - NEEDLE 0 NO NO
VIGNESWARAN 41221 35 M YES NO NO GASTRITIS 2 YES YES
RAMAYEE 41576 52 F NO NO YES GASTRITIS 2 YES YES
KUMARAN 40582 38 M NO YES YES GASTRIC VARICES 2 YES YES
ALBERT 40985 39 M YES YES NO MALLORY WEISS TEAR 1 YES YES
BALA MURUGAN 40791 42 M NO YES NO GASTRITIS 2 YES YES
JAMES  41005 50 M YES YES NO EROSIVE GASTRITIS 3 YES YES
SELVAM 41082 36 M YES YES NO DUODENITIS 3 YES YES
RAMACHANDRAN 42001 29 M YES NO NO GASRRITIS & DUODENITIS 3 YES YES
MUNIYAMMAL 42975 79 F NO NO YES EROSIVE GASTRITIS 4 YES YES
PRATAP 42912 33 M YES YES NO GASTRITIS 2 YES YES
KANDASAMY 42765 46 M YES YES NO EROSIVE GASTRITIS 2 YES YES
SADHASIVAM 42217 55 M YES YES NO GASTRITIS 3 YES YES
PARIMALA 42665 35 F NO NO YES GASTRITIS 1 NO NO
SENTHIL 43167 40 M YES NO NO DUODENITIS 1 NO YES
KUMARAN 43288 42 M YES YES NO OESOPHAGITIS 1 YES YES
RAMANAN 43312 48 M NO NO YES GASTRITIS 2 NO YES
SARAVANAN 43589 24 M YES NO NO DUODENITIS 2 YES YES
ASHIQ 44645 34 M YES NO NO MALLORY WEISS TEAR 1 NO NO
PARTHASARATHY 45623 40 M YES YES NO EROSIVE GASTRITIS 2 YES YES
SIVA MURUGAN 45678 70 M YES NO NO LESSER CURVATURE GROWTH 3 YES NO
MICHAEL 46685 62 M YES YES NO GASTRITIS 3 YES YES
HUSSAIN ALI 46675 54 M YES NO NO 
LOWER OESOPHAGEAL 
VARICES 2 YES YES
BAKIYARAJ 46754 34 M NO NO NO OESOPHAGITIS 2 YES NO
THIRU MOORTHY 46864 28 M YES YES NO DUODENITIS 2 YES YES
KESAVAN 47687 35 M YES NO NO OESOPHAGITIS  2 NO YES
RAMU 47987 75 M YES YES NO DUODENITIS 3 YES YES
MALARVIZHI 46574 40 F NO NO YES GASTRITIS 3 YES YES
RAMESH 47275 35 M YES YES NO DUODENAL ULCER 3 YES YES
YOUNIS KHAN 48124 42 M YES NO NO NORMAL 2 NO NO
BOOBALAN 48235 37 M YES YES NO GASTRITIS 3 YES YES
PARANTHAMAN 48432 38 M NO NO NO OESOPHAGITIS 2 NO NO
BALARAMAN 48356 45 M YES YES NO EROSIVE GASTRITIS 3 YES YES
PARAMASIVAM 47265 38 M YES YES NO MALLORY WEISS TEAR 1 NO YES
SATHISH 48734 35 M YES YES NO GASTRITIS 2 YES YES
MUNUSAMY 49947 42 M YES YES NO EROSIVE GASTRITIS & LAX LES 2 YES YES
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